// App-Quantinova.ai

MA039 : An increased concentration of matrix metalloproteinase-9 in the blood after coronary stenting lasts much longer than the increase of other markers of inflammation

Researchers

Presenter

  • Provatorov S

Principal Investigators

  • Merkulov E

  • Potekhina A

  • Kuznetsova G

  • Samko A

  • Masenko V

  • Noyeva E

  • Zharova E

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Restenosis

  • Angina

Biomarkers

  • High sensitivity C-reactive protein

  • Matrix metallopeptidase 9

  • TIMP Metallopeptidase Inhibitor 1

Drug/Treatment

  • Fibrinogen (IV)

  • Rapacan

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved